Biogen (BIIB) closed near a 52-week low of $150.03. The stock trades at a discount because the biotech firm lacks growth ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.01% of ...

GSK PLC GSK shares rose 1.06% to £13.34 Tuesday, on what proved to be an all-around dismal trading session for the stock ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

Standard Investments, which owns 11% of the FTSE 250 firm, urged the board to launch a strategic review to look at 'a sale of ...

Moderna faces index removal, stock plunge, vaccine challenges, and lawsuits, while focusing on R&D in oncology and rare ...

Shares of GSK PLC GSK inched down 0.75% to £13.20 Monday, on what proved to be an all-around grim trading session for the ...

Canal+ has suffered a disappointing debut on the London Stock Exchange with the French film production firm's shares ...

Shares in French media giant Canal+ fell by 22pc on its first day of trading, dampening optimism around London’s biggest ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK announced that its B7-H3-targeted antibody-drug conjugate, GSK’227, has received ...

An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK announced that its drug Jemperli (dostarlimab) has received the US FDA ...

The FTSE 100 index is set to open 12 points lower at 8289, having fallen by 11 points at the end of last week. Today’s ...